Abscess, Canker Sores & Silver Shield

An abscess is an open wound that exposes the blood and lymph to possible bacterial contamination, so it's vital that you use a quick wound management procedure to get the wound to heal. Apply Silver Shield immediately or as soon as possible to wash away any microbial invaders. You can then use the Silver Shield Gel with a bandage to keep it working.

If you have a large wound, you can spray the Silver Shield liquid on it or use the gel form with bandages also.

The liquid form of Silver Shield can be used in the mouth as a rinse for abscesses. Swish and hold a teaspoon of the liquid in your mouth for six (6) minutes, then swallow, so it will work internally also to fight infections. It is suggested to do this 2-3x a day for one week.

Canker sores have many causes, but an acid pH in the mouth is the most frequent problem. The soft tissue in the mouth gets destroyed by too much sugar and/or bacterial or viral infections. Silver Sol liquid can be used in the same manner as with abscesses above, repeating the process twice a day.

The herpes virus can be another cause of the problem. If the sore is accessible you can also use the Silver Shield gel by putting a dab on it several times a day. The sooner you get it on the less spreading there will be.

Buy Silver Shield at wholesale price.

Book: A Fighting Chance - 2nd Edition

According to the U.S. patent (approved Nov. 2007), Silver Sol has the ability to destroy 143 types of bacteria, both forms of viruses, mold, yeast, and a limited number of parasites. It can also purify water (US Patent Office, Nov. 2006). Silver Sol can be used to treat over three hundred conditions; these are listed in the book "A Fighting Chance" by Dr. Gordon Pedersen.

Dr. Pedersen notes that Silver Sol functions as a non-toxic disinfectant for internal or external use as it comes in three forms: liquid, topical gel, and aerosolized. From toenail fungus to rashes, Silver Sol aids the immune system in reducing the bacteria, viruses, and mold it encounters.

The 2nd Edition of "A Fighting Chance" is a must have for all silver sol users. With 50 pages of new material, this book is even more informative than its predecessor. The new content includes: general uses by body system, updates to the “conditions” helped by silver, and most exciting - a compendium of studies using silver sol and their results. This book is perfect as a gift, or for anyone serious about protecting their health naturally.

It’s no secret that pathogens such as viruses, bacteria, and fungi can inflict terrible damage in the human body. Dozens of diseases—ranging from the common cold and dysentery to meningitis and pneumonia—are caused by infectious pathogens.

These diseases are all around us. We come in contact with countless bacteria everywhere we go. Bacteria are in restaurants, public restrooms, schools, airplanes—all spread by touch or passed through the air. Disease can even result from our own habits, like inadequate sleep or too much stress.

Currently, disease is winning the battle. Each year, we suffer from colds and flus. Likewise, strep throat, sinus infections, and stomachaches attack our health.

Fortunately, a simple, safe, and effective alternative exists. For decades, silver products have been marketed as a medicinal agent for use primarily as a disinfectant. In fact, patents on silver products have existed since the early 1920s. However, earlier versions of silver—called “colloidal silver”—had to be used in large amounts to be effective.

Currently, a new and vastly improved type of silver has been developed that is non-toxic and extremely effective against a wide range of bacteria, viruses, fungus, mold and other pathogens. This silver solution—called simply Silver Sol—is available both as a liquid and gel.

Because we are faced with more diseases than ever before, we need a better solution than ever before. This book outlines some of the health threats facing our modern society and what we can do to have a fighting chance in this battle.

120 pages.

Buy Silver Shield at wholesale price.
Get "A Fighting Chance" book.

Here’s a brief look at Dr Gordon Pedersen, phD, one of the world’s foremost experts on silver sol.

Doctor Pedersen has work experience with the world’s largest pharmaceutical company (Ciba/Novardis), the world’s largest sports nutrition company (Weider), dynamic biotechnology companies like Nikken, has co-authored Chicken Soup for the Enriching Soul, developed and published the mouse model for Influenza, and was an expert research and development author for Muscle and Fitness magazine.

Doctor Pedersen is an internationally renowned scientist, author, corporate officer, product formulator, and technical instructor. He formulates world-class products, expertly documents their benefits, credibly communicates through the use of scientific journals, has created international best selling scientific tools and has been a top executive for the past 11 years.

Doctor Pedersen received his doctorate degree from the Toxicology program at Utah State University where he received two distinguished service awards and constructed two space shuttle experiments. In addition, he has formulated over 160 nutritional supplements/personal care products.

He was one of the first to publish a double blind placebo controlled study on the benefits of protein supplementation in body builders, where he worked with Arnold Schwarzenegger. He was nominated to Chair the United States Pharmacopoeia Review Board (Natural Products Committee), and hosted the radio show, Common Sense Medicine with Dr. Pedersen.

Buy Silver Shield at wholesale price.
Get "A Fighting Chance" book.

Silver Shield Safety

According to the Agency for Toxic Substances and Disease Registry Silver Sol is:

• Not considered to be carcinogenic.

• Completely safe for pregnant women, babies and the elderly.
• Non-toxic to the immune, cardiovascular, nervous or reproductive systems. At doses 200 times the normal adult dose, it is non-toxic to healthy human cells.

The Merck Manual shows that pure metallic silver (Silver Sol) is not categorized as a heavy metal and cannot cause argyria nor heavy metal poisoning. The salt forms of silver are poisonous.

The Physicans Desk Reference shows silver has a long history of being anti-microbial. Silver bandages are given by prescription (Silverlon) and silver has been used for over a hundred years in babies' eyes to kill bacteria after delivery. There are 44 drugs that include silver in them.

Buy Silver Shield at wholesale price.

Silver Sol and MRSA

Silver Sol and The Successful Treatment of Hospital Acquired MRSA

in Human Subjects With Ongoing Infection

Gordon Pedersen, Ph.D.

Toxicologist, American Biotech Labs

Abstract
The patented form of Silver Sol (US Patent # 7135195) has been shown to destroy bacteria, viruses, and mold both in vitro and in living systems.20 Staphylococcus aureus can be completely destroyed by Silver Sol in as little as two minutes and in vitro studies show it will stay dead for 28 days. Rustum Roy Ph.D. reported that strains of methicillin-resistant Staphylococcus aureus (MRSA) could be destroyed by Silver Sol treatment in vitro.

The University of California Berkeley reports that Silver Sol can completely destroy in vitro forms of MRSA and Vancomyocin resistant Enterococcus (VRE) at levels as low as 2.5 ppm in as little as 45 to 60 minutes. With MRSA continuing to mutate and sustain resistance to antibiotics, it is encouraging to report the findings from this study, which demonstrates an all-natural opponent to this modern day plague.

This study demonstrates the benefits of Silver Sol on human subjects with serious MRSA infections of the skin. These patients were hospitalized and contracted their MRSA infections while staying in the hospital. Patients wound size, depth, and closure rates were photographed and digitized for weekly calculations that quantified the time to wound closure and overall seriousness of the infection. Before, during, and after photos demonstrate a visual accounting of the benefit of the Silver Sol treatment. All treatments were given by the hospital medical staff where patients received Silver Sol Gel sprayed topically on the wound twice daily and orally ingested 2 teaspoons of the liquid Silver Sol twice a day.

The results of this study indicate that twice-daily treatment with Silver Sol Gel (spray form) and twice-daily oral ingestion of liquid Silver Sol significantly improved treatment of hospital acquired MRSA infections in human subjects. The average time to closure improved, and patients taking Silver Sol reported a significant reduction in pain associated with the wound.

Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is approaching pandemic levels and there is an immediate need for a substance like Silver Sol in controlling this potentially fatal disease. MRSA is a resistant variation of the common bacterium Staphylococcus aureus, which is resistant to a significant group of antibiotics called beta-lactams, which include penicillins and cephalosporins.1

The organism is often sub-categorized as community-associated MRSA (CA-MRSA) or healthcare associated MRSA (HA-MRSA). CA-MRSA cases were first reported in the late 1980’s. Recently, HA-MRSA has plagued the medical professionals and patients that work or live in hospitals. It is estimated that as much as 60% of hospital nurses carry MRSA in their noses and on their skin.2 MRSA could be considered to be a modern day plague because it has evolved the ability to survive treatment with most antibiotics including methicillin, dicloxacillin, nafcillin, and oxacillin.

Hospitals have a special need for help in patients with open wounds that use invasive devices, or have a weakened immune system, as these patients are at greater risk of MRSA infection. Heightened risk of infection is also seen in the hospital employees who do not follow meticulous hygiene and proper sanitizing procedures. Such employees may self-infect or transfer the contagion to patients or visitors. Indeed, a study reported by the Association for Professionals in Infection Control and Epidemiology, in 2008, concluded that the poor hygiene habits remain the principle barrier to a significant reduction in the spread of MRSA. They also indicate that this hospital risk is exponentially great when you combine the propensity for the general public to spread this superbug in public restrooms, restaurants, airplanes, nurseries, schools, athletic events, and in the home.

MRSA is progressing toward pandemic proportions. The Centers for Disease Control and Prevention (CDC), estimated that the number of MRSA infections in the US doubled in just six years from 127,000 in 1999 to 278,000 in 2005, while at the same time, deaths increased from 11,000 to more than 17,000.2 According to the Journal of the American Medical Association,3 MRSA was responsible for 94,360 serious infections and associated with 18,650 hospital-stay related deaths in the United States in 2005.

MRSA is growing out of control, and the statistics suggest grave outcomes. Liu et al reported that the annual incidence of CA-MRSA in San Francisco residents during 2004-2005 was 316 cases per 100,000 population, while the annual incidence of HA-MRSA was 31 cases per 100,000 population.4 Noskin et al reported that MRSA patients had, on average, three times longer stays (14.3 days versus 4.5 days), incurred three times the expenditure ($48,824 versus $14,141), and experienced five times the risk of in-hospital death (11.2% versus 2.3%) as compared to patients without this infection.5 Whilst Wyllie et al reported that 34% of patients with MRSA died within 30 days of infection.6 Wyllie also reported that the most common sites of infection were the nostrils, respiratory tract, open wounds, intravenous catheters, and urinary tract.

Hospitals in Denmark, Finland, the Netherlands,7 and VA hospitals in Pittsburg report that MRSA infections can be significantly reduced using sanitary methods that include swabbing the nostrils and hands with antibacterial protection. These studies demonstrate the potential benefits of an antibacterial agent used prophylactically on the hands and nostrils as long as resistance is not a potential long term problem.

MRSA is a resistant staphylococcus infection that usually presents as a patch of small pus surrounded by redness and swelling, and resembles pimples, spider bites, or boils. Infection may or may not be accompanied by a fever and rash. The bumps become larger and spread, and larger, painful, pus-filled boils can develop deep into the tissue. Approximately 75% of CA-MRSA infections are localized to the skin and soft tissue, however a minority of these infections spread and affect vital organs, causing sepsis, toxic shock syndrome, and flesh eating (necrotizing) pneumonia.8

At present, it is not fully understood why some healthy people survive MRSA infections and others do not.

The current treatments of MRSA include vancomycin and teicoplanin, which are prescription antibiotics categorized as glycopeptides.9 The absorption of these antibiotics is very poor and they must be given intravenously in order to control systemic infections.10 However, there are several new strains of MRSA that have become resistant even to vancomycin and teiocplanin.11,12 At present, linezolid, quinupristin/dalfopristin, daptomycin and tigecycline are used to treat more severe infections that do not respond to glycopeptides such as vancomycin.13

In addition, oral treatments include linezolid, rifampicin and fusidic acid, rifampicin and fluoroquinolone, pristinamycin, cotrimoxazole, doxycycline or minicycline and clindamycin. Nature14 reported that a new antibiotic called platensimycin has demonstrated MRSA activity.15,16 It should be noted that some of the newest drug discoveries can cost $1600 per day, which may prohibit their ubiquitous distribution.

The spread of MRSA is complicated by the fact that hospitals discharge contagious patients into the community, workforce, schools, and general public.17 In the US, it is estimated that 95 million people carry Staphylococcus aureus in their noses, of these 2.5 million carry MRSA,21 and 23% of these require hospitalization.22 MRSA is nearing pandemic proportions and there is a serious need for a daily use antibacterial that does not produce resistant strains of MRSA.

Currently, Silver Sol may be the only prophylactic use product that has activity against MRSA, and that could be used for prevention as well as treatment of MRSA because it does not produce resistant strains.

Materials and Methods

AHS is a hospital-based elderly health care provider that approved the study of 308 subjects in their elderly care (nursing home) hospitals. The patients were admitted to the hospital without MRSA, but had acquired the MRSA infection while in hospital and the skin infections were ongoing for over one year.

The Medical staff treated and photographed the wounds before any Silver Sol treatment and every week during the treatment. The size and depth of the wounds were measured in centimeters and recorded weekly by the hospital staff. Silver Sol Gel was sprayed (using a hand operated pump spray) on the wounds topically twice a day. Patients answered a questionnaire regarding their wellness, including pain evaluations.

Results
Tables 1, 2, and 3 illustrate significant improvement in the ability of Silver Sol to close a wound and improve the time to wound closure.

Table 1. Percent Wound Closure in HA-MRSA Patients (ongoing 1 year)
% Closed Week 1 Week 2 Week 3 Week 4 Week 5
100 98% 100%
90 97% XXX XXX
80 95% XXX XXX XXX
70 XXX XXX XXX XXX
60 67% XXX XXX XXX XXX
50 XXX XXX XXX XXX XXX
40 XXX XXX XXX XXX XXX
30 XXX XXX XXX XXX XXX
20 XXX XXX XXX XXX XXX
10 XXX XXX XXX XXX XXX
0 XXX XXX XXX XXX XXX

Table 2. Average Wound Size in Centimeters in HA-MRSA Patients
Week 0 Week 1 Week 2 Week 3 Week 4 Week 5
0.25 cm 0.15cm 0.10 cm 0.10 cm 0.10 cm 0.0 cm

Table 3. Summary of Data
Week Size of Wound (cm) % Wound closure
0 0.25 cm 0%
1 0.15 cm 67%
2 0.10 cm 95%
3 0.10 cm 37%
4 0.10 cm 98%
5 0.0 cm 100%

Concluding Remarks
The results of this study strongly suggest that Silver Sol Liquid and Gel demonstrate the ability to destroy HA-MRSA and significantly improve healing outcomes. The results indicate that wounds close as much as three times faster than wounds not treated with Silver Sol, thus quantifying the benefits of Silver Sol. HA-MRSA can be fatal and cause serious infections – even when treated with antibiotics – yet, Silver Sol Gel and Liquid demonstrate improved wound treatment and improved time to wound closure in human subjects.

The improvements in wound healing, as identified by a shorter time to wound closure, suggests that there is an improvement in immune function due to the fact that Silver Sol reduces the bacteria in the wound. By reducing the bacterial infection wound healing improves by approximately three times and reduces pain in the process.

This reduction in pain and improvement to healing can be attributed to the fact that infection, inflammation, and tissue damage are reduced when using Silver Sol, and suggests that there are several beneficial mechanisms of action at work. The fact that there are wounds in this study that are large enough to be difficult or impossible to close on their own, and yet when Silver Sol is used the wounds heal completely, suggest the possibility that stem cell activation is being produced.

By observing the healing results published in this study, it is evident that this remarkable and bactericidal liquid and gel should be considered to be leaders in the defense against HA MRSA.

The improvements demonstrated here suggest that Silver Sol can help improve healing times, which could potentially reduce the overall cost of treatment by as much as three times and reduce the average length of stay in a hospital. This study demonstrates the benefits of Silver Sol in reducing the infectious nature of a skin born disease acquired in a hospital. In today’s world of mutating bacteria and antibiotic resistant infections producing potentially fatal disease, Silver Sol could be the health vector that helps reduce the health risk to all patients, staff and visitors in the hospital. Buy Silver Shield at wholesale price.

References
1. Okuma K, Iwakawa K, Turnidge J, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289–4294. doi:10.1128/JCM.40.11.
2. Klein E, Smith DL, Laxminarayan R. Hospitalizations and Deaths Caused by Methicillin- Resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007;13:1840– 1846.
3. Zeller JL, Burke AE, Glass RM. MRSA Infections. JAMA. 2007;298:1826.
4. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004- 2005. Clin Infect Dis. 2008;46:1637-1646.
5. Noskin GA, Rubin RJ,Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapetina E, Gemmen E. The Burden of Staphylococcus aureus Infections on Hospitals in the United States: An Analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med. 2005;165:1756–1761. doi:10.1001/archinte.165.15.1756.
6. Wyllie D, Crook D, Peto T. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 2006;333:281. doi:10.1136/bmj.38834.421713.2F.
7. McCaughey B. Unnecessary Deaths: The Human and Financial Costs of Hospital Infections. 2nd ed. Available at: http://www.tufts.edu/med/apua/Patients/ridbooklet.pdf. Accessed February 22, 2009.
8. MRSA Toxin Acquitted: Study Clears Suspected Key to Severe Bacterial Illness [news release]. National Institute of Health; November 6, 2006. Available at: http://www3.niaid.nih.gov/news/newsreleases/2006/staphtoxin.htm. Accessed February 22, 2009.
9. Schentag JJ, Hyatt JM, Carr JR, Paladino JA, Birmingham MC, Zimmer GS, Cumbo TJ. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis. 1998;26: 1204-1214. doi:10.1086/520287. 299
10. Janknegt R. The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic, and pharmacoeconomic considerations. Pharm World Sci. 1997;19:133-141. doi:10.1023/A:1008609718457.
11. Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol. 1997;179: 2557-2566.
12. Schito GC. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect. 2006;12 (Suppl 1):3-8.
13. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-associated methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis. 2003;37:1050-1058. doi:10.1086/378277.
14. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate use program. Clin Infect Dis. 2003;36:159-168. doi:10.1086/345744.
15. Bayston R, Ashraf W, Smith T. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother. 2007;59:848-853. doi:10.1093/jac/dkm031.
16. Wang J. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-361.
17. Cooper BS, Medley GF, Stone SP, et al.. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. PNAS. 2004;101:10223-10228. doi:10.1073/pnas.0401324101.
18. Graham P, Lin S, Larson E. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144:318-325.
19. Jernigan JA, Arnold K, Heilpern K, Kainer M, Woods C, Hughes JM. Methicillin-resistant Staphylococcus aureus as community pathogen [conference summary]. Emerg Infect Dis [serial on the Internet]. 2006 Nov. Available from http://www.cdc.gov/ncidod/EID/vol12no11/06-0911.htm. Accessed February 22, 2009.
20. Treatment of humans with colloidal silver composition. US patent 7 135 195. November, 2006.

About The Author
Dr. Gordon Pedersen received his Doctorate degree in Toxicology with emphasis in Virology from Utah State University and a Master's degree in Cardiac Rehabilitation and Wellness.

Dr. Pedersen has authored a number of important protocols in virology. He is the formulator of more than 150 nutritional products, an international best-selling author, and host of the radio show "Common Sense Medicine". He now serves as the Director of the Institute of Alternative Medicine and was nominated to chair the United States Pharmacopoeia Review Board, Natural Products Committee. Buy Silver Shield at wholesale price.

Silver Sol and Homeland Security

Silver Patent Analysis

(U.S. Patent No. 7,135,195)

Silver Shield helps eliminate the following:

• Bacillus Anthracis–Anthrax
• Candida Albicans–Yeast
• YersiniaPestis–Bubonic Plague
• MRSA –Resistant Staph Aureus
• MycobacteriaBovisand TB –Tuberculosis
• Salmonella -Food Poisoning
• Fungal infections of the skin
• Bacterial infections of the skin
• Vaginal & urinary tract infections
• Respiratory & nasal infections
• Conjunctivitis –pink eye

SILVER SHIELD: REVOLUTIONARY SILVER FOR THE BODY!

From a lecture by Dr. Gordon Pedersen (Ph.D. in toxicology with a Master's degree in Wellness)

This special patented colloidal silver worked in 1.2 minutes against the bubonic plague. In the lab they used 160x more plague cells than normal and it killed off 99.9%. This plague killed off over 1/3 of the entire population of Europe. We are going to have modern day plagues ... and we suffer a modern day plague now with MRSA (staph infections). Antibiotics are not helping and people are dying.

This substance has been presented to Homeland Security by Senator Orrin Hatch. General P.K. Carlton, MD, the Director of Integrative Center for Homeland Security has stated in written form:

"I would like to bring to your attention a resource that I feel can be used and utilized in the area of bio-defense from bio-terrorism to infectious diseases such as SARS. The ABL antimicrobial has undergone rigorous testing and has been found to kill anthrax, bubonic plague, hospital staph and SARS. It's the first new antimicrobial for the hospital in many years. In addition the product is non-toxic to humans, this product is EPA approved for hospital staph and bubonic plague and currently awaiting section 18 approval for anthrax. In short, we currently do not have anything with such a wide spectrum of efficacy in our inventory. As such, I recommend that the antimicrobial be evaluated for addition to the national pushback stockpile."

How does silver work? It disables the enzyme that one-celled bacteria, viruses, and fungi need for oxygen metabolism. In the presence of silver, these pathogenic microbes suffocate. Dr. Pederson in his book, "A Fighting Chance – How to Win the War Against Bacteria, Viruses & Mold With Silver," on page 13 states, “Silver Sol is an Ag 404 which means that it is missing two electrons in its outer shell. This means that a Silver Sol has catalytic capabilities. Catalytic means that while one electron is destroying bacteria viruses and mold, the other is being recharged. This catalytic conversion allows the Silver Sol to destroy then instantaneously recharge and: kill: again and again – like a rapid fire machine gun. The result is that Silver Sol can destroy thousands of times more pathogens than a simple colloid or ionic silver. This means that Silver Sol can be much more effective at a very safe concentration (5-20 parts per million), which can be potentially consumed every day.”

In one powerful experiment, 50 gallons of raw sewage were pumped into a pool without any disinfectant. The E. coli count (a standard measure of contamination) was at 7,000 E. coli cells per milliliter of water. The water was exposed to silver electrodes and within three hours, all 50 gallons were free of E. coli.

Silver Shield Colloidal silver is an effective ally in the fight against over 650 disease-causing organisms. These include: bacteria (typhoid, diphtheria, certain types of food poisoning, and pneumonia); viruses (the common cold, influenza, and measles); protozoa (malaria, giardiasis, amebic dysentery); fungi (ringworm, thrush, candida albicans, and athlete's foot); rickettsiae (rocky mountain spotted fever and Q fever); and chlamydiae (infections of the eye, the genitals, and the respiratory system). There is no known microbe that colloidal silver does not destroy.

Silver, however, doesn't destroy beneficial enzymes because they are very different from the enzymes of single-celled life which silver targets. Silver is nontoxic. Also, colloidal silver doesn't interact or interfere with other medicine being taken.

“Based on my research, I have found the new silver solution to be a safe and effective weapon against harmful yeasts, viruses, and bacteria. Its low concentration, high effectiveness, and lack of side effects make it an ideal supplement for the prevention and care of conditions associated with these pathogens.” Kenneth Friedman, Ph.D. (MIT), M.S. (MIT & Harvard)

“To date, there are no potentially pathogenic bacteria tested that...[this] product has not killed.” Dr. R. Leavitt, Professor of Molecular Biology and Microbiology Brigham Young University

View lots of research, a video and other information on this at Silver Shield-Silver Sol website or purchase Silver Shield at wholesale prices.

This website is maintained by TheHerbsPlace.com.

For herbs, supplements, and essential oils guaranteed for purity, shop The Herbs Place - wholesale prices & fast shipping from 4 warehouses. What's On Sale Now?

Silver Fights The Germ War

Antibiotics are becoming more potent and dangerous as their failure rate increases. They are also the cause of new strains of superbugs, like MRSA. Health care costs are rocketing out of control and bioterrorism is a real threat. We've stocked up on this item because of it's effective for many health ailments.

With a variety of viral flu outbreaks, e-coli contamination, and a host of other potential pandemics that create a strain on health in America, the new Silver Shield solution and gel offers a fighting chance in germ warfare.

"Silver has undergone rigorous testing and has been found to kill anthrax, bubonic plague, hospital staph and SARS. This product is EPA approved ... In short, we currently do not have anything with such a wide spectrum of efficacy in our inventory." General P.K. Carlton, M.D., Director of Integrative Center for Homeland Security

How Does Silver Sol Kill Bacteria?

Silver Sol ions are available to act against contaminating bacteria in four (4) ways:

• Silver Shield ions combine with bacterial proteins in the cell and cell wall.

• Silver Shield ions interfere with DNA replication by acting like a magnet that attracts charged DNA particles. The DNA binds so tightly to the silver that it makes a chaotic tangle of incomplete genetic material. This inactivates the virus and blocks replication of it. Normal cells are protected by a thicker cell membrane containing a balanced charge.

• Silver Shield ions promote formation of reactive oxygen species (ROS), thus helping the body rid itself of toxins and foreign invaders through oxidation.

• Silver Shield ions resonate at a frequency selectively destructive to pathogens. In fact, it has been measured to resonate at 890 to 910 terahertz. This is the same frequency at which germicidal ultraviolet light resonates. The tiny silver particles are absorbed into the red blood cells at the perfect frequency to destroy bacteria, viruses, fungus and yeast.

Silver Shield provides a simpler and more economical solution for many health issues besides fighting any invaders that would challenge your immune system.

Silver products have been used safely as antimicrobial agents for many years. Silver is mentioned in the Egyptian writings. Greek and Romans used silver vessels for water purification. In the early plagues, the wealthy used silverware to protect themselves.

Doctors have used silver sutures in surgical wounds and to combat wound infections during WWI. Silver is used widely in hospitals and even commercial airlines use silver water filters. Silver Shield Gel has been FDA approved for treatment of wounds and burns.

Not all silver is alike, so it's important to know what to look for in colloidal silver. There is now technology that makes it safe and non-toxic. The product, Silver Shield, has EPA designation as non-toxic (EPA# K043106) and a US patent (#7,135,195) for safe technology. The fine particle-size colloids ensure maximum efficiency.

Silver Shield has a long shelf life and is a great item to include in your emergency preparedness supplies. With winter on our heels, it's time to get prepared for the first signs of colds and flu so you can ward off any real symptoms and lost work and living time. Buy Silver Shield at wholesale price.

Silver Shield Researched and Approved

Silver sol technology keeps your immune system strong daily. Make it your first line of microbial defense. Silver Shield with patented silver sol technology is:

• EPA designated as non-toxic (EPA# K043106)

• U.S. patent for safe technology (Patent # 7135195)

• FDA approval on the Silver Sol Gel

• Doctor recommended

• Backed by science

• Proven safe in 7 different safety studies

• GSA and VA approved for purchase

• Tested by major universities and certified independent laboratories

• Hundreds of completed tests at government certified laboratories

• Pro-biotic tested and found harmless against friendly bacteria or flora

• Customer proven with over a million bottles sold throughout the world

• Only product of this type to be presented before a congressional hearing on Malaria (Apr 2005)

Buy Silver Shield at wholesale price.

Video: Dr. Pedersen Speaks On Silver Sol Silver Shield

Buy Silver Shield at wholesale price.

Research Studies on Silver Shield

Silver Shield provides a first line of defense to protect our bodies against pathogens that are killing millions of people throughout the world annually. The Silver Solution is an immune-modulator, meaning that it can help a healthy immune system to fight off disease!

Safety Studies

1) NAMSA - Toxicity Tests - found non-toxic at up to 200 times the normal adult dosage.

2) Brigham Young University (Jessica K. Pate, 08/04) - Probiotic Bacteria Study - found that it did not kill probiotic bacteria.

3) Viridis BioPharma - Probiotic Bacteria Study - found that it did not kill probiotic bacteria.

4) Sheri C. Patel Research Centre - Found non-toxic in injection mouse model tests at up to 50 mg/kg (10 ppm).

5) Sheri C. Patel Research Centre - Found non-toxic in oral mouse model tests at up to 5000 mg/kg (32 ppm).

6) Sheri C. Patel Research Centre - Found non-toxic in injected mouse model tests at up to 5000 mg/kg (32 ppm).

7) Viridis BioPharma - Cytotoxicity Study - found non-cytotoxic in human hep2 cell line and also found non-cytotoxic in a Vero cell line (African Green Monkey).

8) Northview Pacific Labs - (13 December,2004) up to 32 ppm Skin irritation tests - The product found non-irritating to the skin.

Human Studies

Four human clinical trial studies in four different hospitals have been completed to date, including 124 patients.

The studies were designed to test the oral use of the product (at 10 ppm) to treat 18 different human ailments and diseases. In these studies there were no failures, and almost all patients were deemed as fully recovered in less than one week.

The studies included ailments such as: upper respiratory tract infections, eye infections, ear infections, urinary tract infections, sore throats, abdominal pain and diarrhea, bronchitis, vaginal yeast infections, external cuts, gonorrhea, pelvic inflammatory disease, various mouth problems, retro viral infections, Malaria, etc. The product was found to be so effective that the country of Ghana approved the product as an antibiotic-alternative drug.

Malaria Testing

The first two human studies looked at Malaria along with 17 other ailments. The second two studies were focused on just the treatment of Malaria following a standard protocol.

To date 54 Malaria patients have officially been treated with the 10 ppm Silver Solution. The ages of the patients involved in the studies have ranged from just one year to 90 years old. Both male and female patients were treated. On average just one ounce of the silver solution was used [in some cases as little as ½ an ounce] daily.

On average full recovery was obtained in 5 days. The shortest recovery times were about 2 days and the longest reported recovery time was about 10 days. A number of the cases were complicated by the fact that the patients were also suffering from other ailments including urinary tract infections, measles and fungal infections and this may have contributed to the increased treatment times.

There were no failures in the testing, all patients achieved full recovery in an average of five days.

Yeast Testing

1) University Of California at Davis (Jason Henrie, 4/13/99) - Yeast Test - found effective in killing S. cerevisiae var and Montrachet forms of yeast.

2) Brigham Young University- Antimicrobial Efficacy Against Vaginal Pathogens When Used As A Suppository - found effective in killing 21 pathogens, including two different types of yeast and one other fungus. Jessica K. Pate, August 2004.

3) Viridis BioPharma (India) - found effective in killing Candida albicans.

4) Analytical Resource Laboratory - found effective at killing Candida albicans.

Silver Shield vs. Bacteria

1) Brigham Young University - Antibiotic Comparison - found more effective and more broad-spectrum than any of the individual antibiotics tested (15 pathogens).

2) Brigham Young University - Activity Against Numerous Pathogenic Bacterium - found effective at killing every pathogenic bacterium it was tested against at less than 10 ppm (17 pathogens).

3) Analytical Resource Laboratory - Rapid Challenge Tests - found effective at killing the MRSA bacterium.

4) Nelson Laboratories, Inc. - Antibacterial Tests - found effective at killing P. aeruginosa, S. Aureus, S. Choleraesuis (120 individual bacterial tests).

5) Nelson Laboratories, Inc. - EPA Tests - found effective at killing P. aeruginosa, S. Aureus, S. Choleraesuis (1620 individual bacterial tests).

6) Nelson Laboratories, Inc. - Tuberculocidal Kill Time Study- 97.3% kill in 45 minutes.

7) Brigham Young University - Sporicidal Activity Bacillus subtilis (anthrax test)- 98.8% kill in 4 hours.

8) Nelson Laboratories, Inc. - Sporicidal Activity Clostridium sporogenes (anthrax test) eliminated all spores in 8 hour study.

9) Brigham Young University - Sporicidal Activity Bacillus subtilis (anthrax Test) - 6 log reduction in 5.02 hours.

10) Illinois Institute Of Technology - Sporicidal Study B. anthracis- 99% kill at 6 hours.

11) Nelson Laboratories, Inc. - Sporicidal Activity (Anthrax AOAC Test) - passed for both Clostridium sporogenes and Bacillus subtilis at 10 hours.

12) Illinois Institute Of Technology - Sporicidal Study (Anthrax AOAC Test) - passed for Clostridium sporogenes at 8 hours.

13) Brigham Young University - Bactericidal Activity Against Y. pestis (Bubonic Plague) (Richard A. Robinson PH.D., 07/08/03)- 10 ppm 99.77% kill in 2 minutes/ 32 ppm greater than a 6 log reduction in less than 2 minutes.

14) Central Utah Water - Bacteria Kill In Water Treatment - killed all bacteria listed as TNTC in raw river water at a dilution of 1/100 (0.10 ppm) in 1.5 minutes of contact time.

15) Central Utah Water - Bacteria Kill In Water Treatment - killed all bacteria listed as TNTC in raw river water at a dilution of 1/200 (0.05 ppm) in 20 minutes of contact time.

16) Grant H. Layton D.D.S. - Dental Unit Water Line Bacteria Biofilm Study - found effective in killing all biofilm and maintaining water purity at a level of 0.50 ppm.

17) Viridis BioPharma - Antimicrobial Tests - found effective at killing 12 pathogens including: MRSA 1, MRSA 2 and Candida albicans.

18) Central Utah Water (Don G. Yates 10/18/04) – Recheck - Bacteria Kill In Water Treatment- killed all bacteria listed as TNTC in raw river water at a dilution of 1/100 (0.10 ppm) in a number of different time frames using both the 10 and 32 products.

Silver Shield Vs. Viruses

1) Viridis BioPharma - Bacteriophage viral model - killed a billion virus in 2.5 hours.

2) Viridis BioPharma - Viricidal Activity against Hepatitis B Virus - found effective in both DNA Polymerase and Reverse Transcriptase inhibition. This test is currently in Peer Review.

3) Haffkine Institute (Dr. R.A. Deshmukh, 12/05/03) - Viricidal Activity against Hepatitis B Virus - found effective in both DNA Polymerase and Reverse Transcriptase inhibition.

4) U.S. National Institute Of Health - SARS Kill Test - 99% Reduction in 60 minutes.

5) Viridis BioPharma - Viricidal Activity against Hep B Virus - Found to be at least twice as effective as a major drug in the Reverse Transcriptase inhibition.

6) Viridis BioPharma- (June, 2005) Full report on SilDustl 100 wound sprinkling powder. The test work includes antimicrobial testing against a viral challenge. The product is designed as a timed-release antimicrobial product. The product was found to kill the virus in three hours.

7) ATS- (November, 2005) Avian Influenza A Reassortant H3-N2 - Both 10 and 32 ppm - Killed 96.8 and 99.0% respectively in 2 hours. No virus found with either 10 or 32 ppm product at 12 hours.

8) ATS- (November, 2005) Beijing Influenza A H1-N1 - Both 10 and 32 ppm - Killed 98.2 and 99.9 % respectively in 2 hours. No virus found with either 10 or 32 ppm product at 12 hours.

9) Utah State University- NIH Lab (April, 2006) Avian Influenza A H5-N1 Vietnam Hybrid- 10 ppm reduced the virus to below detectable levels in 6 hours.

Silver Shield vs. Avian Influenza (H5N1)
Executive Summary by Dr. Gordon Pedersen

There is a need to find a preventive therapy against the fatal virus H5N1 Avian Influenza. In the spring of 2006, Dr. Sidwell and The Institute for Antiviral Research was commissioned to test the Silver Shield 10ppm in vitro against Avian Influenza. Results from that study found that it is effective against the virus when tested in the lab. The following report is from the follow-up study on Avian Influenza H5N1 which was performed on mice. This report gives a determination of the level that the Silver Shield can help prevent death and disease from Avian Influenza H5N1.

H5N1 Experiment

The purpose of this experiment was to determine the silver solution’s potential for preventing Avian Influenza (the Bird Flu-H5N1) in a living model.

The experimental design included 19 mice per treatment group. The mice were treated with the silver solution twice daily for 28 continuous days. The mice were infected with Avian Influenza H5N1 on day 7, and the results were compared to those found in the infected placebo group.

Results of H5N1 Experiment

Survival:
60% of the infected mice treated with the silver solution survived.

30% of the placebo-treated, infected mice survived. This is a 100% improvement in the ability to survive a fatal H5N1 viral infection. This demonstrates how the silver solution provides twice as much prevention against H5N1 influenza when compared to non-treated mice.

This data strongly suggest that the disease is being inhibited and treated. In addition, there were improvements found in the lung scores, lung weights, virus found in the lungs and oxygen circulating in the blood.

Oxygen saturation in the blood

The infected mice treated with the silver solution had a greater oxygen saturation at day 11, than the placebo-treated infected mice. This suggests that the silver solution increased the ability to transfer vital oxygen throughout the body, even when the mice were at the most vulnerable time in the study.

Toxicology Controls

Mice were given a ten times normal dose of 10ppm silver solution. This resulted in 100% of the mice surviving and even thriving. This group of mice, were given extremely high doses of silver solution to determine if very large doses would be toxic. 100% of these mice survived, and even gained weight, demonstrating the safety of the product.

Summary

Silver Shield safely helps prevent death from H5N1 Bird Flu infection, improves oxygen transfer and reduces the severity of the infection.

Silver Shield Vs. Other Microbes

1) Analytical Resource Laboratory - Rapid Challenge Test - found effective at killing Trichomonas vaginalis.

2) Four hospitals in Ghana, West Africa - 3 Human Studies Against Malaria Etc. - found effective in killing the Malaria protozoa and eliminating it from the bloodstream within an average of 3.43 days (study number three).

3) Viridis BioPharma (22 July, 2005) - Malaria trial animal model (Plasmodium berghei) interim report. (10 ppm) Found to have a 94.3% inhibition rate.

4) William Beaumont Army Medical Center (2005) - In Vitro activity against Leishmania Promastigotes. Killed all three types at between 1-2 ppm.

Antibiotic/Silver Shield Combinations

1) Viridis BioPharma- Antibiotic Symbiotic Relationship Study - Found to have a very high symbiotic relationship in killing MRSA etc. with two different antibiotics. Found to be much more effective than either of the antibiotics separately.

2) Viridis BioPharma - Bacterial Activity Of Combinations Of NSS With 19 Antibiotics Against 7 Organisms. Feb 2005. Found to have a synergistic or additive effect with all 18 antibiotics tested.

Other Silver Solution Tests

1) 1000 bottle burn treatment study (Summit Cancer Clinic) - found effective in the treatment of radiation burns at just 10 ppm.

2) FDA burn studies, (Viridis BioPharama) studies for FDA approval, including comparisons to pharmaceutical products - found to be 10 times more effective at killing the MRSA bacterium than a leading pharmaceutical product, even though the leading pharmaceutical product contained over 300 times more of the active ingredient (silver) than the Silver Sol product.

3) Kansas State University - Food disinfection tests (used on beef) - found safe and effective in the killing of bacterium on beef carcasses.

4) A & L Southern Agricultural Laboratories - found effective against Xanthomonas campestris pv. Vesicatoria, plant pathogen.

5) University Of Florida - Pesticide Efficacy Trials For Ornamental Plant Diseases - found to reduce disease leaf spots.

6) Brigham Young University (Jessica K. Pate, 04/04) - Antimicrobial Activity Of Dry 32 ppm on Impregnated Surgical Mask Material- even after the product was dried on the mesh material, the product was found effective at killing bacteria pulled into the mask material.

7) Brigham Young University (Jessica K. Pate, 08/04) - Antimicrobial Activity Of 32 ppm In A Soap Solution - found to be a highly effective antimicrobial even when the product was diluted down to just 5.6 ppm, in a soap matrix. In the test work, the nano-silver product/soap mix, killed 21 pathogenic bacterium, 2 different yeasts, and Trichophyton rubrum (athlete’s foot, jock itch, ringworm).

8) Brigham Young University - Increased Efficacy Of Povidone Iodine 10% Solution When Combined With 32 ppm - found to have a synergistic relationship in disinfection.

9) Penn State, Arizona State, University Of Arizona, Study Of The NSS product. Unique Properties Of this Silver Sol Technology- found to have very unique properties, which are not found in other silver products. This information has been filed for patent.

10) Viridis BioPharma - (June, 2005) Full report on SilDustl 100 wound sprinkling powder. The test work includes antimicrobial testing against three (MDR) Multi Drug Resistant strains of bacteria and one viral challenge. The product is designed as a timed-release antimicrobial product. The product was found to kill the MDR bacteria in minutes and the virus in three hours.

11) Viridis BioPharma - (June, 2005) Full report on treating Multi Drug Resistant (MDR) and Multi Co-therapy Resistant (MCR) mutants using engineered nano silver particle.

12) Viridis BioPharma - (June, 2005) Full report on Prevention of Gentamicin Resistant Mutants by closing Mutant Selection Window (MSW) with engineered nano silver particle.

New Patents

The New Silver Solution product is the only patented engineered nano-silver particle product in the United States. Two U.S. construction patents have been issued. The unique SilverSol Technology(TM) now has a patented construction process [U.S.Patent #6214299], patented particle sizes and many patented end uses [U.S.Patent #7135195]. This patent covers a wide range of pathogens, including: Anthrax and the bacteria that cause Bubonic plague; and Viruses such as Hepatitis B and HIV; and, Parasitic diseases such as Malaria. The patent also includes more common infectious agents and ailments including MRSA , TB, skin infections, ear and eye infections, upper respiratory tract infections, STD's, and others.

Buy Silver Shield at wholesale price.

Effectiveness Of Silver Shield

A. Purpose of Example

The purpose of this example is to demonstrate the utility of silver-based composition embodiments of the present invention for treating a variety of human ailments. The studies in this section were performed in Ghana, West Africa, at the Air Force Station Hospital under the direction of Dr. Kwabiah, at the Korie-Bu Teaching Hospital under the direction of Sr. Sackey, and at the Justab Clinic/Maternity Hospital under the direction of Dr. Abraham.

In total, fifty-eight (58) patients were treated using a composition of the present invention comprising 10 ppm silver. The composition was used both internally and externally as an alternative to traditional antibiotics.

The ailments treated included malaria, upper respiratory tract infections, urinary tract infections, sinusitis, vaginal yeast infections, eye, nose and ear infections, cuts, fungal skin infections, and sexually transmitted diseases, such as gonorrhea.

B. Treatment Methods and Outcomes

Abdominal pain and Diarrhea. The method comprises the step of administering approximately 5 25 ml of silver composition, one to five times a day orally until there was a response. One patient was treated with about 10 ml (about two teaspoons) of a composition of the present invention three times in one day. The patient had a full recovery in one day.

Bronchitis. The method comprises the step of administering 2-25 ml of silver composition orally, one to five times a day until there was a response. Two patients were treated with about 5 ml (about one teaspoon) each of a composition of the present invention for two times a day for three days. The patients had a full recovery in three days.

Vaginal Yeast (Candida). The method comprises the step of administering 5-25 ml of silver composition, one to five times a day as vaginal douches until there was a response. Five patients were treated with about 10 ml (about two teaspoons) each of a composition of the present invention for two times per day. The patients showed a full recovery within six days.

Conjunctivitis. The method comprises the step of administering several drops of a silver composition, one to five times a day to the infected eye until there was a response. Two patients were treated with several drops of a composition of the present invention in each of the infected eyes for two times per day. The patients had a full recovery after one day.

External cuts and infection (including Staphylococcus skin infections, septic ulcers and infected abscesses). The method comprises the step of administering a silver composition, one to five times a day to the infected area until there was a response. Six patients were treated with about 5 ml (about one teaspoon) each of a composition of the present invention on the infected areas for two times per day. The patients showed a full recovery within three days.

External Otitis. The method comprises the step of administering a silver composition, one to five times a day to the infected ear until there was a response. Six patients were treated with approximately two drops of a composition of the present invention into the infected ears for three times per day. The patients showed a full recovery after about four days.

Otitis Media. The method comprises the step of administering a silver composition, one to five times a day to the infected ear until there was a response. One patient was treated with approximately two drops of a composition of the present invention comprising into the infected ear three times per day. The patient showed a full recovery in four days.

Fungal Skin Infection. The method comprises the step of administering a silver composition, one to five times a day topically to the infected area until there was a response. Two patients were treated with about ten ml (two teaspoons) each of a composition of the present invention three times per day. The patients showed a full recovery within eight days.

Gonorrhea. The method comprises the step of administering a silver composition to the infected area until there was a response. Two patients were each treated with about ten ml (two teaspoons) of a composition of the present invention three times per day. The patients showed an absence of symptoms within six days.

Malaria. The method comprises the step of administering a silver composition, one to five times a day orally to the patient until there was a response. Eleven patients were treated with about ten ml (two teaspoons) each of a composition of the present invention three times per day. The patients showed a resolution of symptoms within five days.

Halitosis and Gingivitis. The method comprises the step of administering a silver composition, one to five times a day as a mouthwash until there was a response. Two patients were each treated with the composition as a mouthwash. There was a full resolution of symptoms within three days (gingivitis) and within one day (halitosis).

Pelvic Inflammatory Disease. The method comprises the step of administering about 5 25 ml of silver composition, one to five times a day as a vaginal douche until there was a response. One patient was treated with about 5 ml (approximately one teaspoon) of a composition of the present invention two times per day. The patient's symptoms resolved within five days.

Pharyngitis. The method comprises the step of administering a silver composition, one to five times a day as a gargle until there was a response. Four patients were each treated with about ten ml (two teaspoons) of a composition of the present invention three times per day. The patients showed full recovery within six days.

Retrovirus Infection (HIV). The method comprises the step of administering a silver composition, comprising 5 to 40 ppm silver one to five times a day orally area until there was a response. One patient exhibiting HIV (human immunodeficiency virus )was treated with about 5 ml (approximately one teaspoon) of a composition of the present invention two times per day. The patient's symptoms resolved within five days.

Sinusitis and Rhinitis. The method comprises the step of administering a silver composition, one to five times a day to the nose until there was a response. Six patients with nasal infections (four with sinusitis and two with rhinitis) were each treated with approximately two drops of a composition of the present invention comprising in their nasal passages three times per day. The patients showed full recovery within four days.

Tonsillitis. The method comprises the step of administering a silver composition, one to five times a day as a gargle until there was a response. One patient was treated with a composition of the present invention three times per day. The patient showed full recovery within seven days.

Upper Respiratory Tract Infection. The method comprises the step of administering a silver composition, one to five times a day orally until there was a response. Two patients were each treated with about 5 ml (approximately one teaspoon) of a composition of the present invention three times per day. The patients showed full recovery within six days.

Urinary Tract Infections. The method comprises the step of administering a silver composition, one to five times a day orally until there was a response. Three patients were each treated with about ten ml (two teaspoons) of a composition of the present invention two to three times per day. The patients showed full recovery within six days.

C. Discussion

These results are consistent with the various in vitro tests reported herein. Essentially, the silver composition is extremely effective against a large number of microbes in vitro. However, the tests indicate that this effectiveness remains even in the presence of a large amount of organic material.

The silver compositions are widely effective in vivo where the organic background is extremely high. Many other disinfecting agents are ineffective in the presence of a large amount of organic material and/or are too caustic or toxic to be used in vivo.

Get detailed scientific information on the U.S. Patent Website.
Buy Silver Shield at wholesale price.

How Does Colloidal Silver Work?

It disables the enzyme that one-celled bacteria, viruses, and fungi need for oxygen metabolism. In the presence of silver, these pathogenic microbes suffocate.

In one powerful experiment, 50 gallons of raw sewage were pumped into a pool without any disinfectant. The E. coli count (a standard measure of contamination) was at 7,000 E. coli cells per milliliter of water. The water was exposed to silver electrodes and within three hours, all 50 gallons were free of E. coli.

Colloidal silver is an effective ally in the fight against over 650 disease-causing organisms. These include: bacteria (typhoid, dyptheria, certain types of food poisoning, and pneumonia); viruses (the common cold, influenza, and measles); protozoa (malaria, giardiasis, amebic dysentery); fungi (ringworm, thrush, candida albicans, and athlete's foot); rickettsiae (rocky mountain spotted fever and Q fever); and chlamydiae (infections of the eye, the genitals, and the respiratory system). There is no known microbe that colloidal silver does not destroy.

It turns out that silver ions are very important for the immune system. They supplement and support the T-cells in fighting foreign organisms, almost forming a second immune system. In research done with AIDS, it appears that silver both protects and defends T-cells, and does their work for them. There is also a correlation between occurrence of illness and the level of silver in the body; people who are ill generally register lower levels of silver in their body.

Besides suffocating unwanted invaders, colloidal silver also helps injured tissues grow back. It has been useful in cases of severe burns and broken bones. It reduces scar tissue and helps severe cuts and wounds heal faster.

In prolonged, very heavy doses, some colloidal silver compounds will leave deposits in the heavier skin folds, like the knuckles. This permanent gray coloring of the skin is called Argyria; it is correctable with laser treatment. Argyria is very rare and most often associated with products that use particles of silver which are too large to be flushed out of the body's system naturally.

As long as the silver particle size ranges from .005 to .015 microns in diameter, there should be no problem. Silver Shield meets these requirements.

Simple 1-2-3 of How Silver Shield Works

1) The silver oxide coating of the nano-particle kills bacteria by pulling away one of the electrons on the bacteria cell membrane, which contributes to the rupture of the membrane and ultimately the death of the bacteria cell.

2) The special nano-silver process creates an electro-magnetic charge. Bacteria, like a virus DNA, have incomplete segments of DNA that have abnormal electrical charges. This silver nano-particle is magnetically attracted to the virus and overpowers its DNA by causing the DNA to bind into a tight ball. This renders the virus incapable of reproducing.

3) The special silver process has a magnetic resonance which is destructive to bacteria and viruses. Dr. Ruston Roy, Penn State University, has found these nano-particles resonate at between 890-910 tetrahertz, which is the same frequency that most labs use to protect doorways and counters in a lab from bacterial and viral contamination.

Buy Silver Shield at wholesale price.

Silver vs. Antibiotics

An antibiotic kills a half-dozen different disease organisms. But because the antibiotic attacks the bacteria directly, and because bacteria adapt very well, they mutate to over-come the antibiotic. So every time an antibiotic is used, it becomes less effective for the next time it is needed.

But silver kills over 650 disease causing organisms, and it can do so every time. No resistant strains develop with the use of silver. Researchers speculate that this is because silver does not attack the microbe directly like an antibiotic does. It decomposes the enzyme microorganisms rely on to breathe-they can't mutate to counterattack silver's approach.

Another problem with antibiotics is that they kill beneficial enzymes while attacking the bad ones; pharmaceutical antibiotics can't distinguish between good and bad enzymes. This is why the immune system is especially weak after a round of antibiotics, and why yeast infections are much more likely after taking antibiotics.

Silver, however, doesn't destroy beneficial enzymes because they are very different from the enzymes of single-celled life which silver targets. Silver is nontoxic. Also, colloidal silver doesn't interact or interfere with other medicine being, taken.

Finally, antibiotics only affect bacteria. Silver disables bacteria, viruses, fungi, and all other disease causing organisms.

Buy Silver Shield at wholesale price.